RFQ-FDA-134493_Amendment_0002.pdf

PDF 94 KB Posted

Attached to
Weekly Dry Ice Supply and Delivery Services
Solicitation number
RFQ-FDA-134493
Issued by

About this file

This is an Amendment to Solicitation document that cancels a Request for Quotation (RFQ) in its entirety.

The U.S. Food and Drug Administration, through Contracting Officer Sarah Hussain, issued Amendment 0002 to RFQ-FDA-134493 effective August 21, 2026, canceling the solicitation for Weekly Dry Ice Supply and Delivery Services. No further quotations will be solicited, accepted, or evaluated under this solicitation number, and no award will be made. The Government determined that cancellation is appropriate because the requirement requires further internal review and revision before competition, and proceeding to award would not be in the Government's best interest. The cancellation is issued under the Government's reserved right per FAR 52.212-1(d). No purchase order or contract has been awarded or accepted under this solicitation. Any previously submitted quotations will not be evaluated and will not result in award. Offerors will not be charged any fees or penalties, and the Government assumes no liability for costs incurred by offerors in preparing or submitting quotations. This notice supersedes RFQ-FDA-134493 and Amendment 0001 in their entirety, and no further amendments, questions and answers, or solicitation actions will be issued under this solicitation number.

View the file

Other files

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

AMENDMENT TO SOLICITATION

Cancellation of Solicitation

Solicitation No.: RFQ-FDA-134493

Amendment No.: Amendment 0002 to RFQ

Title: Weekly Dry Ice Supply and Delivery Services

Effective Date: August 21, 2026

Issued By:

U.S. Food and Drug Administration — Contracting Officer:

Name: Sarah Hussain

Email: sarah.hussain@fda.hhs.gov

Phone: 301-796-3940

Section 1: Description

The purpose of Amendment 0002 to RFQ-FDA-134493 is to cancel the solicitation in its entirety, effective immediately. No further quotations will be solicited, accepted, or evaluated under this solicitation number, and no award will be made under RFQ-FDA- 134493.

Section 2: Basis for Cancellation

The Government has determined that cancellation of this solicitation is appropriate for two reasons: (1) the requirement, as written, requires further internal review and revision before it can be competed; and (2) proceeding to award under the solicitation as currently written would not be in the Government's best interest. This cancellation is issued under the Government's right, reserved at RFO 52.212-1(d), Instructions to Offerors—Commercial Products and Commercial Services, to reject any or all offers when such action is in the public interest. No purchase order or contract has been awarded or accepted under this solicitation.

Section 3: Effect on Offerors

1. Any quotations already submitted in response to RFQ-FDA-134493 will not be evaluated and will not result in award. No further action by offerors is required.

2. Offerors will not be charged any fee or penalty as a result of this cancellation, and the Government assumes no liability for costs incurred by offerors in preparing or submitting quotations.

Except as cancelled herein, this notice supersedes RFQ-FDA-134493 and Amendment 0001 in their entirety. No further amendments, questions and answers, or solicitation actions will be issued under solicitation number RFQ-FDA-134493.

File details come from the government source that posted it. Updated .